Skip to content
value.today

Pervasive Health, Inc.

🇺🇸 Chicago, Illinois, USAHealth CareFounded 2012
Total raised
$26 M
3 rounds on record
Latest round
$23 M
Oct 2019
First round on record
Apr 2012
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Pervasive Health, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2019$23 MNo. 3$10 to $50 million

Pervasive Health, Inc.: Raise no. 3, Oct 2019

Investors in this round

17 investors had bought by the notice of Oct 15, 2019: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$23 M of $23 M offered
Smallest investment taken
$26,543
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Blackford Middleton · Executive Officer
  • Kenneth Jakobsen · Executive Officer
  • Kevin Hutchinson · Executive Officer, Director
  • Kevin Weinstein · Executive Officer
  • Michael Oltman · Executive Officer
  • William McNally · Executive Officer
  • Adam Koopersmith · Director
  • James Bradley · Director
  • Mark Achler · Director
  • Michael Liang · Director
  • Sarah London · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by William McNally, SVP Finance. Source: SEC Form D, newest notice filed Oct 15, 2019. Read the notice at the SEC.

equitySEC
May 2013$1 MNo. 2Under $2 million

Pervasive Health, Inc.: Raise no. 2, May 2013

Investors in this round

9 investors had bought by the notice of Jun 7, 2013: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $5 M offered; $4 M still to sell
Smallest investment taken
$10,000
What was sold
equity, debt
Exemption claimed
  • Rule 505: the former limited-offering exemption (withdrawn in 2017)
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
$60,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Aaron Symanski · Executive Officer
  • Geoff Phillips · Executive Officer, Director, Promoter
  • Paul Magelli · Executive Officer, Director, Promoter
  • Rick Halton · Executive Officer

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds of the offering may be used as monthly compensation for Related Persons described herein for post-offering services in the amount stated above.”

Signed by Paul Magelli, Chief Executive Officer & President. Source: SEC Form D, newest notice filed Jun 7, 2013. Read the notice at the SEC.

equity, debtSEC
Apr 2012$2 MNo. 1Under $2 million

Pervasive Health, Inc.: Raise no. 1, Apr 2012

Investors in this round

17 investors had bought by the notice of Dec 11, 2012: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered; $0 M still to sell
Smallest investment taken
$10,000
What was sold
debt, options or other rights to buy securities, other: Convertible Promissory Notes
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
$350,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Paul J Magelli · Executive Officer, Director, Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Reimbursement of pre-incorporation costs expended on behalf o issuer & compensation for post-incorporation services.”

Signed by Paul J. Magelli, Chief Executive Officer/Incorporator. Source: SEC Form D, newest notice filed Dec 11, 2012. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Pervasive Health, Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2019).

    SEC Form D · Oct 2019

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Oct 2019

That is all the official record says: Pervasive Health, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Pervasive Health, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 17 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Pervasive Health, Inc.
NameRoleNamed in
Blackford MiddletonExecutive officerOct 2019
Kenneth JakobsenExecutive officerOct 2019
Kevin HutchinsonExecutive officerOct 2019
Kevin WeinsteinExecutive officerOct 2019
Michael OltmanExecutive officerOct 2019
William McNallyExecutive officerOct 2019
Aaron SymanskiExecutive officerJun 2013
Geoff PhillipsExecutive officerJun 2013
Paul MagelliExecutive officerJun 2013
Rick HaltonExecutive officerJun 2013
Paul J MagelliExecutive officerDec 2012
Adam KoopersmithDirectorOct 2019
James BradleyDirectorOct 2019
Kevin HutchinsonDirectorOct 2019
Mark AchlerDirectorOct 2019
Michael LiangDirectorOct 2019
Sarah LondonDirectorOct 2019
Geoff PhillipsDirectorJun 2013
Paul MagelliDirectorJun 2013
Paul J MagelliDirectorDec 2012
Geoff PhillipsPromoterJun 2013
Paul MagelliPromoterJun 2013
Paul J MagelliPromoterDec 2012